Cite
HARVARD Citation
Hays, J. et al. (n.d.). Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) - Phase 2 Study of MLN0128 (TAK-228) in Patients with Tumors with TSC1 or TSC2 Mutations: Sub-protocol EAY131-M. European journal of cancer. pp. S25-. [Online].